Victory Capital Management Inc Navidea Biopharmaceuticals, Inc. Transaction History

Victory Capital Management Inc

  • $95.8 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020
SELL
$0.7 - $4.16 $1,682 - $9,996
-2,403 Closed
0 $0
Q1 2020

May 04, 2020
BUY
$0.76 - $1.54 $779 - $1,580
1,026 Added 74.51%
2,403 $2,000
Q4 2019

Feb 04, 2020
SELL
$0.65 - $1.26 $956 - $1,854
-1,472 Reduced 51.67%
1,377 $2,000
Q3 2019

Nov 12, 2019
BUY
$0.5 - $0.91 $1,424 - $2,592
2,849 New
2,849 $2,000

Others Institutions Holding NAVB

# of Institutions
3
Shares Held
10.4K
Call Options Held
0
Put Options Held
0
View Full List

About NAVIDEA BIOPHARMACEUTICALS, INC.

NAVB Quotes by TradingView
  • Ticker NAVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,150,900
  • Description
  • Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...
More about NAVB
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email